The nation's first clinical trial testing stem cells in patients with the neurological disorder known as Lou Gehrig's disease is expected to expand this summer to the University of Michigan, and will start examining whether it could be a potential new therapy.
http://www.detroitnews.com/apps/pbcs.dll/article?AID=2013304180372
http://www.detroitnews.com/apps/pbcs.dll/article?AID=2013304180372
No comments:
Post a Comment